Health score, competitive moat, risk signals, and key metrics at a glance.
Competitive analysis based on 5 quarters of fundamental data
Operating margins are expanding at ~13.2%, suggesting durable pricing power and cost discipline.
Limited ROE data for a reliable assessment.
5 of the last 5 quarters generated positive FCF. The company generally funds itself but has occasional cash consumption quarters.
Data-driven red flags and warnings across 5 quarters
Margins are stable or improving at ~13.5% — no sign of cost or pricing stress.
FCF/Net Income has dropped below 0.7x in 4 quarters — monitor for earnings quality deterioration.
D/E ratio is 0.2 — conservative capital structure with low financial risk.
Revenue is stable or growing over recent quarters — demand appears durable.
Free cash flow is consistently positive — the business self-funds without external capital reliance.
Shares decreased 4.7% — net buybacks are reducing shares outstanding and boosting per-share value.
as of June 2025
Revenue, EBITDA, operating income, net income, EPS, and shares
Gross, EBITDA, operating, and net margin trends
P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield
Total assets, cash, debt, book value, and leverage
Operating cash flow, free cash flow, FCF margin, and earnings quality
Revenue has been flat or declining over recent quarters, which may indicate eroding demand or competitive pressure.
